Vascular development involves not only vascular growth (sprouting, proliferation, and branching), but also regression of established blood vessels (Potente et al., 2011) . The hyaloid vasculature is a temporary circulatory system formed in the eyes of a fetus that immediately regresses after birth in mice and by the fifth month of gestation in humans as the growing retinal vasculature takes over the role of the hyaloid vasculature to supply oxygen and nutrients to retinal tissues (Lang and Bishop, 1993; Silbert and Gurwood, 2000) . In humans, failure of the hyaloid vessels to regress leads to an ocular pathology called persistent hyperplastic primary vitreous (PHPV), which causes severe intraocular hemorrhage and impairs visual function (Silbert and Gurwood, 2000) . This programmed regression of hyaloid vessels is partly controlled by macrophages that secrete factors that mediate cell death in the endothelium, such as Wnt7b (Lang and Bishop, 1993; Lobov et al., 2005) . Here, we show that this switch is also triggered by another process orchestrated by neurons. Our data indicate that retinal neurons ultimately control the precise switch from the fetal to the postnatal circulatory systems by timely sequestering vascular endothelial growth factor (VEGF).
RES ULTS AND DIS CUS SION
Neuronal VEGF expression correlates with the number of hyaloid vessels Our first step was to reliably visualize the entire hyaloid vessel structure. For this purpose, we isolated the hyaloid vessels en bloc with the iris, which acted as a frame (Fig. 1 A) . Using this technique, we succeeded in visualizing the hyaloid vasculature together with the associated macrophages ( Fig. 1, B-D) . We also detected spontaneous endothelial apoptosis and vascular regression marked by collagen IV + vascular endothelial cadherin − cord-like structures ( Fig. 1 , E-G). In agreement with a previous study (Rao et al., 2013) , hyaloid vessels did not grow after postnatal day 3 (P3) and were almost completely regressed before P12 (Fig. 1, H-J) .
Retinal neurons contribute to the formation of retinal vessels both in physiological and pathological conditions (Sapieha et al., 2008; Usui et al., 2015) . Retinal neurons are also suggested to act on hyaloid vasculature (Xu et al., 2004; Kurihara et al., 2010) , in part by secreting VEGF (Rao et al., 2013) . Therefore, we generated mice lacking Vegfa in retinal neurons using Pax6α-Cre or Chx10-Cre. The Cre recombination for Pax6a-Cre occurs in the peripheral area of retinas (Marquardt et al., 2001) , whereas it occurs for Chx10-Cre in all retinal neurons (Fig. 1, K and L). The Cre recombinase was not active in endothelial cells and macrophages in hyaloid Vascular development involves not only vascular growth, but also regression of transient or unnecessary vessels. Hyaloid vasculature is the temporary circulatory system in fetal eyes, which spontaneously degenerates when the retinal blood vessels start to grow. Failure of the hyaloid vessels to regress leads to disease in humans, persistent hyperplastic primary vitreous, which causes severe intraocular hemorrhage and impairs visual function. However, the mechanism underlying the endogenous program that mediates spontaneous regression of the hyaloid vessels is not well understood. In this study, we identify a robust switch triggering this program directed by neurons in mice. Marked up-regulation of vascular endothelial growth factor (VEGF) receptor 2 (VEG FR2) occurs in retinal neurons just after birth via distal-multipotent-mesodermal enhancer, a hemangioblast-specific enhancer of VEG FR2. Genetic deletion of neuronal VEG FR2 interrupts this program, resulting in massive hyaloid vessels that persist even during late postnatal days. This abnormality is caused by excessive VEGF proteins in the vitreous cavity as a result of impairment in the neuronal sequestration of VEGF. Collectively, our data indicate that neurons trigger transition from the fetal to the postnatal circulatory systems in the retina. (Fig. 1 V) . In contrast, Vegfa
Developmental regression of hyaloid vasculature is triggered by neurons
Δneuro showed greatly reduced hyaloid vessels compared with control mice at P3 (Fig. 1, W and X) when the hyaloid vessels started to regress, suggesting that VEGF signaling is associated with the formation of hyaloid vessels as well as their maintenance.
VEGF maintains hyaloid vessels via endothelial VEG FR2
Based on existing data, we suspected that the Vegfa Δneuro mouse phenotype could be attributed to VEGF actions on macrophages. Therefore, we first determined the number and morphology of macrophages associated with hyaloid vessels but found no difference between control and Vegfa Δneuro mice (Fig. 2 , A-C). Using bacterial artificial chromosome (BAC)-transgenic mice (Ishitobi et al., 2010) , we detected expression of VEGF receptor 1 (VEG FR1) and VEG FR2 in endothelial cells, whereas their reporter activities in macrophages were below detectable levels (Fig. 2 , D-I). We then generated tamoxifen-inducible endothelial-specific VEG FR2 knockout mice (Vegfr2 iΔEC ) by using Cdh5-BAC-Cre ERT2 (Okabe et al., 2014) . We found that tamoxifen treatment after P2 in mutant mice markedly reduced the number of hyaloid vessels at P6, similar to what was observed in Vegfa Δneuro mice (Fig. 2 , J, L, N, P, and R). Moreover, a single tamoxifen injection 24 h before sacrifice at P6 was sufficient to significantly reduce hyaloid vessels (Fig. 2 , K, M, O, Q, and S). These data suggest that the regression rate of hyaloid vessels highly depends on endothelial VEG FR2 signaling.
VEG FR2 is markedly up-regulated via distal-multipotentmesodermal enhancer (DMME) in retinal neurons after birth Because neuronal VEGF is essential for hyaloid vasculature maintenance, we hypothesized that the timed regression of hyaloid vessels after birth might be caused by physiological down-regulation of neuron-derived VEGF. However, the results of our quantitative PCR analysis indicated that Vegfa expression was not significantly different before and after birth (Fig. 3, A and B) . Immunohistochemistry of retinal sections confirmed that VEGF proteins were constantly detected in retinal neurons, although expression levels gradually decreased 2 wk after birth (Fig. 3, D-H) . The abundant expression of VEGF proteins in the outer segments of adult eyes is in agreement with the strong expression of VEGF genes in the retinal pigment epithelium (Saint-Geniez et al., 2006) . In contrast, Vegfr2 expression was markedly up-regulated immediately after birth (Fig. 3 C) . Because retinal neurons are the major source of VEG FR2 in neonatal retinas (Okabe et al., 2014) , we compared embryonic and neonatal retinas derived from Vegfr2-BAC-GFP mice. Importantly, we found that VEG FR2 expression in embryonic retinas was much weaker than that in P1 retinas (Fig. 3, I -P). DMME is a recently discovered hemangioblast-specific enhancer of VEG FR2, which contains Gata-, Cdx-, Tcf/Lef-, ER71/Etv2-, and Fox-binding sites (Ishitobi et al., 2011) . We recently found that DMME is activated in neonatal neurons but not endothelial cells in the retina (Okabe et al., 2014) . Here, using transgenic mice carrying the DMME-GFP transgene (Ishitobi et al., 2011) , we found that DMME activity was abundant in the neurons of P1 retinas but below detectable levels in embryonic retinas (Fig. 3 , Q and R). To determine whether DMME activation is functionally involved in the neonatal up-regulation of VEG FR2 in neurons, we analyzed VEG FR2 expression in mice lacking DMME (Vegfr2 ΔDMME/DMME ). The peripheral half of the retina at P2, which does not contain endothelial components, showed one third the expression of Vegfr2 in Vegfr2 ΔDMME/DMME compared with that in wild-type pups (Fig. 3 S) . This low Vegfr2 expression still remaining in the Vegfr2 ΔDMME/DMME retina indicated that a regulatory mechanism other than DMME maintains baseline expression of VEG FR2 in retinal neurons.
Lack of neuronal VEG FR2 leads to persistent hyaloid vessels
To examine the roles of neuronal VEG FR2, we generated mice lacking VEG FR2 in retinal neurons using Chx10-Cre (Vegfr2 Δneuro ). The density of the hyaloid vasculature in the resulting mutant mice was much greater than that in control mice at P6 (Fig. 4, A-F and O) . Although the amount of hyaloid vessels present did not differ between control and Vegfr2
Δneuro at P3, the dense network of hyaloid vessels in the Vegfr2
Δneuro mouse persisted even at P12, a time when hyaloid vessels are normally almost completely diminished (Fig. 4, M-O; unpublished data) . This time course in vascular density indicated that the defect in the hyaloid vasculature in the Vegfr2
Δneuro mouse was attributable to impaired regression but not increased formation. Although macrophage numbers were not changed, endothelial apoptosis and vascular regression were markedly reduced in Vegfr2
Δneuro mice (Fig. 4 , G-L, P, and Q). The neuronal integrity and morphology were intact in Vegfr2
Δneuro mice (unpublished data). Vegfr2 ΔDMME/DMME mice showed a slight but significant increase in the number of hyaloid vessels at P6 (Fig. 4 R) , reflecting their low Vegfr2 expression. Premature intraretinal vascularization, as seen in the peripheral retinas of mice with a Pax6α-Cre-mediated Vegfr2 deletion (Okabe et al., 2014) , was observed in all areas of the retina in Vegfr2 Δneuro mice (Fig. 4 , S-W).
Deletion of VEGF normalizes persistent hyaloid vessels in neuronal VEG FR2 knockout mice
Because increased VEGF production from retinal neurons is suggested to cause persistence of hyaloid vessels in Frizzled-4-deficient mice (Rattner et al., 2014) , we measured the VEGF protein level in Vegfr2 Δneuro mice. Importantly, we found markedly increased VEGF protein levels in the vitreous cavity of Vegfr2
Δneuro mice (Fig. 5 B) , whereas the mRNA level of Vegfa was not changed (Fig. 5 A) . It is possible that the lack of soluble VEG FR2 (sVEG FR2), formed by a splice variant of the Vegfr2 gene (Albuquerque et al., 2009) , could increase the level of vitreous VEGF proteins, resulting in persistent hyaloid vessels. Therefore, we examined mice lacking sVEG FR2 but not membrane-bound VEG FR2 (Vegfr2
Δs/Δs
). The results showed that lack of sVEG FR2 did not affect hyaloid vessels (Fig. 5,  C and D) , suggesting that sequestration of VEGF by sVEG FR2 is not associated with this process. Next, we generated mice lacking both Vegfa and Vegfr2 in retinal neurons (Vegfa; Vegfr2 Δneuro ). We found that deleting neuronal Vegfa normalized persistent hyaloid vessels and the absence of spontaneous endothelial apoptosis in Vegfr2
Δneuro mice (Fig. 5 , E-O). Collectively, we identified a switch of the timed regression of hyaloid vessels. Neonatal but not embryonic neurons sequester VEGF protein in the vitreous cavity through binding to VEG FR2, causing endothelial apoptosis, switching the eyes from a fetal to a postnatal circulatory system (Fig. 5 P) .
In terms of the pupillary membrane, another transient circulatory system in fetal eyes (Lang and Bishop, 1993) , the phenotype was not apparent in Vegfr2
Δneuro mice (unpublished data). We speculate that the soluble form of VEG FR1, known to be expressed in the cornea (Ambati et al., 2006) , might be important for the sequestration of VEGF that leads to the regression of the pupillary membrane.
In humans, bilateral PHPV occurs in patients with Norrie disease, which is caused by a mutation in genes coding for the proteins involved in the signaling complex for Norrin (Ye et al., 2010) . Interestingly, mice lacking Norrin show abundant up-regulation of VEGF in neurons, and blocking VEGF corrected the vascular defects in those mice (Xu et al., 2004; Wang et al., 2012; Rattner et al., 2014) . Our present data fully support this scenario: persistent hyaloid vessels are ascribed to increased VEGF protein levels, occurring through either their overproduction or defective sequestration of VEGF by neurons.
Finally, our data identified that neuronal VEGF sequestering triggers the programmed regression of hyaloid vessels. It will be interesting to determine whether this mechanism holds true for the human pathology in PHPV.
MAT ERI ALS AND MET HODS
Mice. All procedures involving animals were approved by the Institutional Animal Care and Use Committee of Keio University and performed in accordance with the Guidelines of Keio University for Animal and Recombinant DNA Experiments. Chx10-Cre mice (Muranishi et al., 2011) or Pax6α-Cre mice (provided by P. Gruss, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany; Marquardt et al., 2001) were mated with Vegfa-flox mice (Genentech; Gerber et al., 1999) and/or Vegfr2-flox mice (Okabe et al., 2014 ) to obtain neuron-specific Vegfa and/or Vegfr2 knockout mice. Vegfr2
Δs/Δs , Cdh5-BACCre ERT2 (Okabe et al., 2014) , Vegfr1-BAC-DsRed, Vegfr2-BAC-EGFP (Ishitobi et al., 2010) , Vegfr2-DMME-EGFP, and Vegfr2 ΔDMME/ΔDMME mice were previously described (Ishitobi et al., 2011) . 40 µg 4-hydroxytamoxifen was subcutaneously injected at the indicated time. Littermates were used as controls. All aforementioned mice were maintained on a C57BL/6J background.
Preparation of retinal sections. Enucleated eyes were fixed for 10 min in 4% paraformaldehyde in PBS, and then hemispheres were cut. After overnight postfixation, samples were snap frozen in optimal cutting temperature compound (Sakura). All specimens were sectioned 10-60 µm thick at the plane of the optic disk.
Preparation of whole-mount hyaloid vessels and retinas. Enucleated eyes were fixed for 20 min in 4% paraformaldehyde in PBS and then dissected. A small hole was made in the cornea using a 27-gauge needle, and a circular incision was made using fine scissors. After removal of the lenses through the pupils, hyaloid vessels were isolated en bloc with the iris, which acted as a frame. After that, retinal cups were dissected as described previously (Kubota et al., 2009) . The wholemount tissues were postfixed for 30 min and then stained as described in the following section.
Whole-mount immunostaining. Immunohistochemistry of whole-mount samples or tissue sections was performed as previously described (Kubota et al., 2009) . The primary monoclonal antibodies used were hamster anti-CD31 (MAB1398Z; EMD Millipore), PDG FRα (14-1401; eBiosci- Δneuro mice and is recovered in Vegfr2;Vegfa Δneuro mice (arrowheads in M). (P) Schematic diagram depicting the transition of ocular circulatory systems. Bars: (C-G) 500 µm; (H-J) 200 µm; (K-M) 50 µm. *, P < 0.05; **, P < 0.01; two-tailed Student's t tests. Representative confocal images from four independent experiments (four mice per group) are shown. Data are represented as mean ± SD. Cont, control; ECs, endothelial cells. ence), vascular endothelial cadherin (550548; BD), and F4/80 (MCA497R; Serotec). The primary polyclonal antibodies used were Alexa Fluor 488-conjugated anti-GFP (A21311; Molecular Probes), collagen IV (LSL-LB-1407; Cosmo Bio), anti-VEGF (sc-152; Santa Cruz Biotechnology, Inc.), and cleaved caspase-3 (9664; Cell Signaling Technology). The secondary antibodies used were Alexa Fluor 488 fluorescenceconjugated IgGs (Molecular Probes) or Cy3/Cy5 DyLight 549/DyLight 649-conjugated IgGs (Jackson ImmunoResearch Laboratories, Inc.). For nuclear staining, specimens were treated with DAPI (Molecular Probes). In some experiments, blood vessels and monocyte lineage cells were simultaneously visualized using biotinylated isolectin B4 (B-1205; Vector Laboratories) followed by fluorescent streptavidin conjugates (Molecular Probes).
Confocal microscopy. Fluorescent images were obtained using a confocal laser-scanning microscope (FV1000; Olympus). Quantification of cells or substances of interest was conducted on a 500 × 500-µm field for vessel length or a 300 × 300-µm field for the number of macrophages, apoptotic cells, and collagen IV + iB4
− cord-like structures per sample in scanned images. Multiple slices horizontally imaged from the same field of view at 0.5-µm intervals were integrated to construct three-dimensional images using an FV10-ASW Viewer (Olympus).
Intraocular injections.
Injections into the vitreous body were performed using 33-gauge needles, as described previously (Okabe et al., 2014) . 0.5 µl sterile PBS with or without 0.1 mg/ml Flt1-Fc chimera proteins (R&D Systems) was injected at P4.
Western blotting. Western blot analysis was performed as described previously (Okabe et al., 2014) . The primary antibodies used were anti-VEGF (sc-152; Santa Cruz Biotechnology, Inc.) and HSC 70 (sc-7298; Santa Cruz Biotechnology, Inc.). The fluids of the vitreous cavity were harvested by rinsing posterior segments of eyeballs with PBS and then thoroughly removing the few cellular components via centrifugation.
Quantitative RT-PCR analysis. Total RNA was prepared from retinal tissues, and reverse transcription was performed using Superscript II (Invitrogen). Quantitative PCR assays were conducted with a real-time PCR system (ABI 7500 Fast) using PCR master mix (TaqMan Fast Universal; Applied Biosystems) and a TaqMan gene expression assay mix of vegfa (Mm00437304_ml) and vegfr2 (Mm00440099_ml). A mouse β-actin (Mm00607939_s1) assay mix served as an endogenous control. Data were analyzed using SDS software (1.3.1.; 7500 Fast System). Each experiment was performed with four replicates from each sample, and the results were averaged.
Statistics. Results are expressed as the mean ± SD. The comparisons between the means of the two groups were evaluated using a two-tailed Student's t test. P-values <0.05 were considered statistically significant.
